课题基金 / 基金详情

Exhaustive analysis about juvenile idiopathic arthritis by using an anti-IL-6 receptor antibody

Exhaustive analysis about juvenile idiopathic arthritis by using an anti-IL-6 receptor antibody
使用抗 IL-6 受体抗体对幼年特发性关节炎进行详尽分析
批准号:
16390305
负责人:
YOKOTA Shumpei
金额:
$9.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

YOKOTA Shumpei的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We analyzed the identification of the target molecule of the IL-6 obstruction treatment by using proteomics method such as 2D-DIGE (fluorescent labeling 2 dimension differential gel electrophoresis) and iTRAQ (Isotope Tag for Relative and Absolute Quantitation) method. Additionally, we examined the role of IL-6 on Kawasaki disease or CINCA syndrome as an axis of this research.Furthermore, we would like to analyze the IL-6 diseases (cytokine-related disease) in pediatric field, and to examine the structure and/or the function of the obstruction target molecule of antiIL-6 receptor antibody treatment front and back in detail in future. Finally, in this study, we detected lots of proteins in sera and plasma of JIA patients using two methods, 2D-DIGE and iTRAQ and could identify some of them.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊: JAMA (under construction)
影响因子: --
作者: [Yokota S, Mori M]
通讯作者: Mori M
Proposal for Juvenile Idiopathic Arthritis Guidance on Diagnosis and Treatment in Primary Care (2007)
青少年特发性关节炎初级保健诊断和治疗指南提案(2007 年)
DOI: --
发表时间:
期刊: Modern Rheumatology (in print)
影响因子: --
作者: [Yokota S, Mori M.]
通讯作者: Mori M.
Therapeutic Efficacy of Humanized Recombinant Anti-IL 6-receptor Antibody in Children with Systemic-onset Juvenile Idiopathic Arthritis.
人源化重组抗 IL 6 受体抗体对全身性幼年特发性关节炎儿童的治疗效果。
DOI: --
发表时间: 2005
期刊: Arthritis Rheum 52
影响因子: --
作者: [Shumpei Yokota, Takako Miyamae, Iwata N, Katakura S, Mori M, Woo P, Nishimoto N, Yoshizaki K, Kishimoto T.]
通讯作者: Kishimoto T.
Tocilizumab, Anti-IL-6 Receptor Monoclonal Antibody : Randomized, Double-blind, Placebo-controlled, Withdrawal Phase III Trial of Efficacy and Safety against Systemic-onset Juvenile Idiopathic Arthritis
托珠单抗,抗 IL-6 受体单克隆抗体:针对全身性幼年特发性关节炎的有效性和安全性的随机、双盲、安慰剂对照、停药 III 期试验
DOI: --
发表时间:
期刊: NEJM (in print)
影响因子: --
作者: [Yokota S, Imagawa T.]
通讯作者: Imagawa T.
Analysis and therapeutic research for growth impairment accompanied with chronic inflammatory syndrome of children as dysregulation of proinflammatory cytokines
  • 批准号:
    23591546
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.33万
  • 财政年份:
    2011
  • 负责人:
    YOKOTA Shumpei
  • 依托单位:
TLR/Nod proteins in infants from dysregulation Pathological analysis Cytokine Storm
  • 批准号:
    19390287
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $12.23万
  • 财政年份:
    2007
  • 负责人:
    YOKOTA Shumpei
  • 依托单位:
Elucidation of pathogenesis of influenza-related encephalopathy using functional failure in rat glia cells
PATHOPHYSIOLOGY OF INTRACRANIAL CYTOKINES IN INFLUENZA-ASSOCIATED ENCEPHALOPATHY
  • 批准号:
    12470169
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $3.9万
  • 财政年份:
    2000
  • 负责人:
    YOKOTA Shumpei
  • 依托单位:
国内基金
海外基金
早期滋养型肠内营养联合益生菌对重症卒中患者喂养耐受性及TNF-α/IL-6水平的影响研究
七氟烷通过调控IL-6/FSP1轴抑制心肌铁死亡减轻心肌缺血再灌注损伤的机制研究
  • 批准号:
    JCZRLH202601296
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
盐酸小檗碱抑制NF-κB/IL-6/STAT3信号通路重塑免疫微环境并增敏肺癌免疫治疗的研究
  • 批准号:
    JCZRLH202600985
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
双歧杆菌与消退素RvD1协同调控IL-6/STAT3/Notch信号轴介导结肠癌EMT及免疫调节的机制研究
  • 批准号:
    JCZRLH202601410
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: